Biopharma Business

Tag "study"

Ingestible balloon could help reduce obesity

    Ingestible balloon could help reduce obesity

A new study has shown that an ingestible gastric balloon could be used to help obese people lose weight without the need for invasive surgery. When swallowed the Elipse balloon

Read Full Article

Data extraction could lead to faster drugs, study says

    Data extraction could lead to faster drugs, study says

  The results from the asthma arm of the world’s first digitally enhanced Randomised Controlled Trial (RCT) have been announced. The Salford Lung Study (SLS) was unique in that it

Read Full Article

HIV Treatment Development Extends Life Expectancy by 10 Years

    HIV Treatment Development Extends Life Expectancy by 10 Years

According to a new study, the life expectancy of 20-year-olds starting HIV treatment has increased by a decade in the EU and North America. A massive new study from the

Read Full Article

Phase 3 readout keeps Amgen in pole position for CGRP migraine drug

Amgen has firmed up its lead in the race to bring the first CGRP inhibitor to market for migraine after presenting positive results from its two phase 3 trials. The

Read Full Article

Allergan and Novartis Collaborate on Multi-Therapy Treatment for NASH

Allergan, a global biopharmaceutical company, announced that it has entered into a clinical trial agreement with Novartis to conduct a Phase 2b study, using Allergan’s cenicriviroc (CVC) and Novartis’ lead FXR

Read Full Article

Trial of new triple inhaler shows 20 percent reduction in COPD flare-ups

Flare-ups in chronic obstructive pulmonary disease, the UK’s fourth leading cause of death, can be reduced by 20% by a combined triple inhaler, according to the results of a trial

Read Full Article

FDA Approves More Drugs, and Faster, than Europe, Study Says

Contrary to some political claims, the U.S. Food and Drug Administration approved more drugs, and two to three months faster on average, than European regulators did in recent years, new research shows. “It’s

Read Full Article

Data Supports Advancement of Botox as Depression Treatment

Allergan plc, a global pharmaceutical company announced topline data from a phase II study with major depressive disorder (MDD). The study evaluated the efficacy, safety and tolerability of a single administration

Read Full Article

Alzheimer’s disease linked to the metabolism of unsaturated fats

  A new study published in PLOS Medicine’s Special Issue on Dementia has found that the metabolism of omega-3 and omega-6 unsaturated fatty acids in the brain are associated with

Read Full Article

Physical inactivity and sedentary behaviors associated with cardiometabolic risk factors

The results are from the first investigation to be conducted with baseline data from the PREDIMED-PLUS study, an 8-year multicenter clinical trial based on a nutritional intervention involving an energy-restricted

Read Full Article

Merck pulls plug on late-stage Alzheimer’s trial

Merck & Co has terminated a Phase II/III trial testing its investigational medicine verubecestat in patients with mild to moderate Alzheimer’s disease. The move came after an external data monitoring

Read Full Article

Encouraging clinical results for an antibody drug to prevent or treat HIV

A new biologic agent – the most potent of its kind so far – is showing early promise as part of a potential new strategy for treating HIV. The drug,

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements